Atlas Trials

Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects

Clinical trial NCT01113320 · COMPLETED

Trial details

NCT number
NCT01113320
Sponsor
Newron Pharmaceuticals SPA
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2010-04-01
Primary completion
2011-11-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.